Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.
PrivateLast Round
Series B
Aug 1, 2021
Company Overview
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a biotechnology company that specializes in the research and development of personalized dendritic cell vaccines for the treatment of malignant solid tumors and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Comparables
Compare Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hengsai Biotechnology | 85% | |
| Diakonos Oncology | 82% | |
| Northwest Biotherapeutics Inc | 78% |
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 1, 2021 | ||||
| Series A | Nov 16, 2020 | ||||
| VC Round | Jul 1, 2019 | ||||
| VC Round | Sep 1, 2018 |
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HMC Ventures | Series A |
| 北京首都科技发展集团有限公司 | VC Round |
| 华创资本 | VC Round |
| 久银控股 | Series B |
| Cowin Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2021
Raised Series B round with participation from 久银控股.
- Nov 16, 2020
Raised Series A led by HMC Ventures.
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s valuation, stock price, and market status.
Is Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. a public or private company?
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a private company.
What is the current stock price of Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.?
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. worth (valuation)?
Valuation information for Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is not publicly available.
Can I buy Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. stock?
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s last funding round?
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s most recent funding round was Series B on August 1, 2021.
Who are the main investors in Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.?
Key investors in Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. include HMC Ventures.
Will Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. IPO soon?
No public IPO plans have been announced for Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd..
How can I track Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s secondary market activity and sign up for updates.